![](/wp-content/uploads/2018/10/vbLC76TGR3ayd9kQq03k.png)
$599
Sanofi Follows Lilly and Novo’s Insulin Price Cuts
Sanofi announced it will cut the Lantus WAC price by 78% and cap the monthly out-of-pocket cost at $35 for commercially insured patients. Additionally, Sanofi will cut the WAC price of Apidra by 70%. The move follows similar insulin price cuts by Lilly (previous FENIX insight) and Novo Nordisk (previous FENIX insight). According to the press release, the price decreases will take effect on January 1, 2024. Below, FENIX provides an updated insulin pricing analysis.